YM BioSciences Presents CYT387 Data at International Leukemia Conference
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), is presenting on its JAK1/2 inhibiting small molecule at the New Directions…
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), is presenting on its JAK1/2 inhibiting small molecule at the New Directions…
YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and…
YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), announced that the merger of Cytopia Limited, the Australian biopharmaceut…
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), announced that the FDA has advised the Company that it may now enroll patie…
YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), a life sciences product development company that identifies and advances…